These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2656908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH, Beames MP, Kuhns MC, Hoofnagle JH, Di Bisceglie AM.
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [Abstract] [Full Text] [Related]

  • 3. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
    Carreño V, Porres JC, Mora I, Bartolomé J, Bas C, Gutiez J, Cortés J, Hernández Guio C.
    Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
    Takkenberg B, Terpstra V, Zaaijer H, Weegink C, Dijkgraaf M, Jansen P, Beld M, Reesink H.
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
    [Abstract] [Full Text] [Related]

  • 6. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.
    Heijtink RA, Kruining J, Honkoop P, Kuhns MC, Hop WC, Osterhaus AD, Schalm SW.
    J Med Virol; 1997 Nov; 53(3):282-7. PubMed ID: 9365897
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V.
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [Abstract] [Full Text] [Related]

  • 11. [Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody].
    Thiers V, Bouchardeau F, Courouce AM, Tiollais P, Brechot C.
    Presse Med; 1986 Jun 28; 15(26):1219-22. PubMed ID: 2944091
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV.
    Antivir Ther; 2007 Jun 28; 12(5):705-18. PubMed ID: 17713154
    [Abstract] [Full Text] [Related]

  • 14. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G.
    Ital J Gastroenterol; 1996 Jun 28; 28(6):324-31. PubMed ID: 8891847
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases.
    Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kajiyama W, Shingu T, Hayashida K, Kaji M.
    Gastroenterol Jpn; 1988 Apr 28; 23(2):117-23. PubMed ID: 3384275
    [Abstract] [Full Text] [Related]

  • 16. Comparison of a quantitative standardized HBV-DNA assay and a classical spot hybridization test in chronic active hepatitis B patients undergoing antiviral therapy.
    Zarski JP, Kuhns M, Berck L, Degos F, Schalm SW, Tiollais P, Bréchot C.
    Res Virol; 1989 Apr 28; 140(4):283-91. PubMed ID: 2772413
    [Abstract] [Full Text] [Related]

  • 17. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.
    Rijckborst V, Hansen BE, Cakaloglu Y, Ferenci P, Tabak F, Akdogan M, Simon K, Akarca US, Flisiak R, Verhey E, Van Vuuren AJ, Boucher CA, ter Borg MJ, Janssen HL.
    Hepatology; 2010 Aug 28; 52(2):454-61. PubMed ID: 20683945
    [Abstract] [Full Text] [Related]

  • 18. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y, Sheng QJ, Zhang C, Wu YY, Yuan SY, Xia TT, An ZY, Dou XG.
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb 20; 27(2):106-111. PubMed ID: 30818914
    [Abstract] [Full Text] [Related]

  • 19. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH.
    Ann Intern Med; 1991 Apr 15; 114(8):629-34. PubMed ID: 2003708
    [Abstract] [Full Text] [Related]

  • 20. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
    Lee SD, Tong MJ, Wu JC, Lin HC, Tsai YT, Lo KJ.
    J Hepatol; 1991 Mar 15; 12(2):246-50. PubMed ID: 2051004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.